You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Murine Gammaherpesvirus M2 Gene Is Latency-Associated and Its Protein a Target for CD8+ T Lymphocytes
S. Mazher Husain, Edward J. Usherwood, Heather Dyson, Christopher Coleclough, Michael A. Coppola, David L. Woodland, Marcia A. Blackman, James P. Stewart and Jeffery T. Sample
Proceedings of the National Academy of Sciences of the United States of America
Vol. 96, No. 13 (Jun. 22, 1999), pp. 7508-7513
Published by: National Academy of Sciences
Stable URL: http://www.jstor.org/stable/48089
Page Count: 6
You can always find the topics here!Topics: T lymphocytes, Genes, Infections, 3T3 cells, RNA, Cell lines, Messenger RNA, B lymphocytes, Complementary DNA, Open reading frames
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Murine gammaherpesvirus 68 (MHV-68) infection of mice is a potential model with which to address fundamental aspects of the pathobiology and host control of gammaherpesvirus latency. Control of MHV-68 infection, like that of Epstein-Barr virus, is strongly dependent on the cellular immune system. However, the molecular biology of MHV-68 latency is largely undefined. A screen of the MHV-68 genome for potential latency-associated mRNAs revealed that the region encompassing and flanking the genomic terminal repeats is transcriptionally active in the latently infected murine B-cell tumor line S11. Transcription of one MHV-68 gene, that encoding the hypothetical M2 protein, was detected in virtually all latently infected S11 cells and in splenocytes of latently infected mice, but not in lytically infected fibroblasts. Furthermore, an epitope was identified in the predicted M2 protein that is recognized by CD8+ T cells from infected mice and a cytotoxic T lymphocyte line that recognizes this epitope killed S11 cells, indicating that the M2 protein is expressed during latent infection and is a target for the host cytotoxic T lymphocyte response. This work therefore provides essential information for modeling MHV-68 latency and strategies of immunotherapy against gammaherpesvirus-related diseases in a highly tractable animal model.
Proceedings of the National Academy of Sciences of the United States of America © 1999 National Academy of Sciences